References
- Shehab N, Lovegrove MC, Geller AI, et al. US emergency department visits for outpatient adverse drug events, 2013-2014. Jama. 2016 Nov 22 316(20):2115–2125.
- Sarkar U, Lopez A, Maselli JH, et al. Adverse drug events in U.S. adult ambulatory medical care. Health Serv Res. 2011 Oct;46(5):1517–1533.
- Budnitz DS, Shehab N, Lovegrove MC, et al. US emergency department visits attributed to medication harms, 2017-2019. Jama. 2021 Oct 5 326(13):1299–1309.
- Oktora MP, Denig P, Bos JHJ, et al. Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States. PloS one. 2019;14(3):e0214240.
- National Center for Chronic Disease Prevention and Health Promotion. A program guide for public health; partnering with pharmacists in the prevention and control of chronic diseases [Pamphlet (or booklet)]. National Center for Chronic Disease Prevention and Health Promotion 2012 [2022 May 24]. Available from: https://stacks.cdc.gov/view/cdc/12103
- American Pharmacists Association. Pharmacists’ impact on patient safety 2022 [2022 May 24]. Available from: https://www.pharmacist.com/Portals/0/PDFS/Practice/PharmacistsImpactonPatientSafety_Web.pdf?ver=dYeAzwlN3-PG9eSkMMsV-A%3d%3d
- Goode JV, Owen J, Page A, et al. Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States. Pharmacy (Basel). 2019 Aug 4;7(3). 10.3390/pharmacy7030106.
- Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010 Oct;48(10):923–933.
- Tan EC, Stewart K, Elliott RA, et al. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014 Jul-Aug;10(4):608–622.
- Kucukarslan S, Lai S, Dong Y, et al. Physician beliefs and attitudes toward collaboration with community pharmacists. Res Social Adm Pharm. 2011 Sep;7(3):224–232.
- Johnson M, Jastrzab R, Tate J, et al. Evaluation of an academic-community partnership to implement MTM services in rural communities to improve pharmaceutical care for patients with diabetes and/or hypertension. J Manag Care Spec Pharm. 2018 Feb;24(2):132–141.
- Ensing HT, Koster ES, Dubero DJ, et al. Collaboration between hospital and community pharmacists to address drug-related problems: the HomeCoMe-program. Res Social Adm Pharm. 2019 Mar;15(3):267–278.
- Duncan P, Ridd MJ, McCahon D, et al. Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study. Br J Gen Pract. 2020 Mar;70(692):e155–e163.
- Larson C, Saine D. Medication safety officer’s handbook. Bethesda, MD: American Society of Health-System Pharmacists; 2013.
- U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion. National Action Plan for Adverse Drug Event Prevention. Washington DC: Author; 2014.
- Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2009 Jul;8(3):CD000072.
- O’Daniel M, Rosenstein AH. Professional communication and team collaboration. In: Hughes RG, editor. Patient safety and quality: an evidence-based handbook for nurses. Rockville (MD): AHRQ Publication; 2008.
- Bardet JD, Vo TH, Bedouch P, et al. Physicians and community pharmacists collaboration in primary care: a review of specific models. Res Social Adm Pharm. 2015 Sep-Oct;11(5):602–622.
- Chui MA, Stone JA, Odukoya OK, et al. Facilitating collaboration between pharmacists and physicians using an iterative interview process. J Am Pharm Assoc. 2014 Jan-Feb;54(1):35–41.
- Bankes DL, Schamp RO, Knowlton CH, et al. Prescriber-initiated engagement of pharmacists for information and intervention in programs of all-inclusive care for the elderly. Pharmacy (Basel). 2020 Feb 21;8:(1):24. doi:10.3390/pharmacy8010024.
- Omboni S, Caserini M. Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases. Open Heart. 2018;5(1):e000687.
- Weissenborn M, Haefeli WE, Peters-Klimm F, et al. Interprofessional communication between community pharmacists and general practitioners: a qualitative study. Int J Clin Pharm. 2017 Jun;39(3):495–506.
- Odukoya OK, Stone JA, Chui MA. Barriers and facilitators to recovering from e-prescribing errors in community pharmacies. J Am Pharm Assoc. 2015 Jan-Feb;55(1):52–58.
- Hincapie AL, Alamer A, Sears J, et al. A quantitative and qualitative analysis of electronic prescribing incidents reported by community pharmacists. Appl Clin Inform. 2019 May;10(3):387–394.
- Zielinska-Tomczak L, Cerbin-Koczorowska M, Przymuszala P, et al. How to effectively promote interprofessional collaboration? - a qualitative study on physicians’ and pharmacists’ perspectives driven by the theory of planned behavior. BMC Health Serv Res. 2021 Sep 2 21(1):903.
- Chen TF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging. 2016 Mar;33(3):199–204.
- Van C, Mitchell B, Krass I. General practitioner-pharmacist interactions in professional pharmacy services. J Interprof Care. 2011 Sep;25(5):366–372.
- Loffler C, Koudmani C, Bohmer F, et al. Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study. BMC Health Serv Res. 2017 Mar 21 17(1):224.
- Jove AM, Fernandez A, Hughes C, et al. Perceptions of collaboration between general practitioners and community pharmacists: findings from a qualitative study based in Spain. J Interprof Care. 2014 Jul;28(4):352–357.
- Rakvaag H, GE SO, Meland E, et al. Complementing or conflicting? How pharmacists and physicians position the community pharmacist. Pharm Pract (Granada). 2020 Jul-Sep;18(3):2078.
- Bollen A, Harrison R, Aslani P, et al. Factors influencing interprofessional collaboration between community pharmacists and general practitioners-A systematic review. Health Soc Care Community. 2019 Jul;27(4):e189–e212.
- Pojskic N, Mackeigan L, Boon H, et al. Ontario family physician readiness to collaborate with community pharmacists on drug therapy management. Res Social Adm Pharm. 2011 Mar;7(1):39–50.
- Gordon C, Unni E, Montuoro J, et al. Community pharmacist-led clinical services: physician’s understanding, perceptions and readiness to collaborate in a Midwestern state in the United States. Int J Pharm Pract. 2018 Oct;26(5):407–413.
- Curran GM, Freeman PR, Martin BC, et al. Communication between pharmacists and primary care physicians in the midst of a U.S. opioid crisis. Res Social Adm Pharm. 2019 Aug;15(8):974–985.
- Perera PN, Guy MC, Sweaney AM, et al. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP). Journal of managed care pharmacy: JMCP. 2011 Jun;17(5):345–354.
- Snyder ME, Zillich AJ, Primack BA, et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm. 2010 Dec;6(4):307–323.
- Damiaens A, Fraeyman J, Fakroune S, et al. General practitioners and community pharmacists’ collaboration in primary care: small steps for a major change. Int J Integr Care. 2021 Apr 23 21(2):10.
- Zillich AJ, McDonough RP, Carter BL, et al. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004 May;38(5):764–770.
- Keijsers CJPW, Dreher R, Tanner S, et al. Interprofessional education in geriatric medicine. Eur Geriatric Med. 2016 [2016 Jul 01];7(4):306–314.
- Kooienga S, Singh RL. Pharmacy and primary care perspectives on e-prescribing in a rural community: a focused ethnography. Res Social Adm Pharm. 2017 Jul - Aug;13(4):820–830.
- Rupp MT. 10 ways to improve medication safety in community pharmacies. J Am Pharm Assoc. 2019 Jul - Aug;59(4):474–478.
- Wust KL, Carayon P, Werner NE, et al. Older adult patients and care partners as knowledge brokers in fragmented health care. Hum Factors. 2022;13:187208221092847.
- Garfield S, Furniss D, Husson F, et al. How can patient-held lists of medication enhance patient safety? A mixed-methods study with a focus on user experience. BMJ Qual Saf. 2020 Sep;29(9):764–773.
- Chae SY, Chae MH, Isaacson N, et al. The patient medication list: can we get patients more involved in their medical care? J Am Board Fam Med. 2009 Nov-Dec;22(6):677–685.
- Bader L, Kusynova Z, Duggan C. FIP perspectives: realising global patient safety goals requires an integrated approach with pharmacy at the core. Res Social Adm Pharm. 2019 Jul;15(7):815–817.
- Seamon GJ, Burke A, Tak CR, et al. Role of pharmacists in hormonal contraceptive access: a survey of north carolina pharmacists. Pharmacy (Basel). 2020 Oct 16 8(4):191.
- Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017 Mar;38:3–11.
- Martin P, Tamblyn R, Benedetti A, et al. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. Jama. 2018 Nov 13 320(18):1889–1898.
- Korenvain C, MacKeigan LD, Dainty KN, et al. Exploring deprescribing opportunities for community pharmacists using the behaviour change wheel. Res Social Adm Pharm. 2020 Dec;16(12):1746–1753.
- Gerlach N, Michiels-Corsten M, Viniol A, et al. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study. BMC Fam Pract. 2020 Sep 4 21(1):183.